BlackRock Capital Allocation Trust (BCAT) Research
The BlackRock Capital Allocation Term Trust (BCAT) is a recently established, closed-end investment management company. As a non-diversified entity, it currently operates without a prior operational track record. Its primary goal is to achieve a blend of total return and income for investors, which it aims to do by generating immediate income streams, realizing short-term profits, and fostering long-term capital growth. The Trust's main office is situated in Wilmington, Delaware.
Market snapshot
- Symbol
- BCAT
- Price
- $15.86
- Day change
- +1.34%
- Market cap
- $1.7B
- P/E ratio
- 7.59x
- 52-week range
- 13.73-16.05
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- BlackRock Enhanced Equity Dividend Trust (BDJ)
- BlackRock Health Sciences Trust II (BMEZ)
- BlackRock Science and Technology Trust (BST)
- Blackrock Municipal 2030 Target Term Trust (BTT)
- Champlain Small Company Fund Institutional Class (CIPNX)
- BlackRock ESG Capital Allocation Trust (ECAT)
- Fidelity Advisor Dividend Growth Z (FZADX)
- SEI Institutional International Trust Emerging Markets Equity Fund Class Y (SEQFX)
Recent insider activity
- Thompson Sarah Croughan — M-Exempt (693.8508 shares) on 2026-01-30
- Thompson Sarah Croughan — M-Exempt (693.8508 shares) on 2026-01-30
- Thompson Sarah Croughan — D-Return (693.8508 shares) on 2026-01-30
- Koesterich Russell Jared — M-Exempt (5554.0398 shares) on 2026-01-30
- Koesterich Russell Jared — D-Return (5554.0398 shares) on 2026-01-30
Open BlackRock Capital Allocation Trust (BCAT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.